Compare AEHL & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEHL | BJDX |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 2.2M |
| IPO Year | 2007 | 2021 |
| Metric | AEHL | BJDX |
|---|---|---|
| Price | $3.00 | $1.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 10.0M | 111.2K |
| Earning Date | 12-26-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,773,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $55.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.99 | N/A |
| 52 Week Low | $1.13 | $1.04 |
| 52 Week High | $11.53 | $10.20 |
| Indicator | AEHL | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 30.14 |
| Support Level | $2.88 | $1.13 |
| Resistance Level | $3.21 | $1.30 |
| Average True Range (ATR) | 0.56 | 0.10 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 66.35 | 3.61 |
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.